Overview
Child and Adolescent Anxiety Disorders (CAMS)
Status:
Completed
Completed
Trial end date:
2008-03-01
2008-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This randomized, controlled trial compared the efficacy of the medication sertraline (Zoloft®), cognitive-behavioral therapy, the combination of these treatments, and placebo for youth with anxiety disorders.Phase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Johns Hopkins University
National Institute of Mental Health (NIMH)Collaborator:
National Institute of Mental Health (NIMH)Treatments:
Sertraline
Criteria
Inclusion Criteria:- Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for separation
anxiety disorder, social phobia, or generalized anxiety disorder
Exclusion Criteria:
- Major neurological disorder or medical illness that would interfere with participation
in the study